The product is a generic version of Ancobon Capsules, 250 mg and 500
mg, of Bausch Health US, LLC, the Bengaluru- headquartered
pharmaceutical company said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-receives-usfda-approval-for-flucytosine-capsules/articleshow/75245163.cms
Sunday, April 19, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment